By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > General > Trazodone

Trazodone

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|589 words

What is Trazodone?

Trazodone is an antidepressant medication that belongs to a class of drugs called serotonin antagonist and reuptake inhibitors (SARIs). Originally developed and approved for treating major depressive disorder, it is now commonly prescribed off-label for insomnia due to its sedating properties. The medication works differently from other antidepressants and has a unique dual mechanism of action.

Uses

  • Major depressive disorder: The primary FDA-approved use, particularly effective for patients with depression accompanied by anxiety or sleep disturbances
  • Insomnia: Widely prescribed off-label for sleep disorders, especially in patients who cannot tolerate traditional sleep medications
  • Anxiety disorders: Sometimes used as an adjunct treatment for generalized anxiety disorder and panic disorder
  • Post-traumatic stress disorder (PTSD): May help with sleep disturbances and nightmares associated with PTSD
  • Chronic pain: Occasionally used off-label for certain types of chronic pain conditions, particularly when sleep disturbance is a factor

How it works

Trazodone blocks serotonin reuptake, allowing more of this mood-regulating neurotransmitter to remain available in the brain. Additionally, it blocks certain serotonin receptors and histamine receptors, which contributes to its sedating effects. This dual mechanism makes it effective for both mood disorders and sleep problems, distinguishing it from other antidepressants.

Side effects

Common side effects:

  • Drowsiness and sedation
  • Dizziness and lightheadedness
  • Dry mouth
  • Headache
  • Nausea
  • Constipation
  • Blurred vision
  • Fatigue

Serious side effects requiring immediate medical attention:

Submit Your Paper
GMJ_Submit_Banner
  • Priapism (prolonged, painful erection lasting more than 4 hours)
  • Irregular heartbeat or chest pain
  • Severe allergic reactions with rash, swelling, or difficulty breathing
  • Suicidal thoughts or behavior, especially in young adults
  • Serotonin syndrome symptoms (confusion, fever, rapid heart rate, muscle rigidity)

Warnings and precautions

  • Suicide risk: Like all antidepressants, trazodone carries an FDA black box warning for increased suicidal thoughts and behaviors in children, adolescents, and young adults under 25
  • Cardiac conditions: Should be used cautiously in patients with heart disease, as it can cause changes in heart rhythm and blood pressure
  • Pregnancy and breastfeeding: Classified as pregnancy category C; potential risks and benefits should be carefully weighed with healthcare providers
  • Liver and kidney impairment: Dosage adjustments may be necessary for patients with hepatic or renal dysfunction
  • Elderly patients: Increased sensitivity to side effects, particularly sedation and dizziness, which may increase fall risk

Interactions

  • MAO inhibitors: Can cause dangerous serotonin syndrome; must allow adequate washout period between medications
  • Other serotonergic drugs (SSRIs, SNRIs, tramadol): Increased risk of serotonin syndrome when combined
  • Blood thinners (warfarin): Trazodone may increase bleeding risk by affecting platelet function
  • CYP3A4 inhibitors (ketoconazole, ritonavir): Can increase trazodone levels, potentially causing increased side effects
  • Digoxin: Trazodone may increase digoxin blood levels, requiring monitoring
  • Alcohol and CNS depressants: Enhanced sedation and respiratory depression risk
  • St. John’s Wort: May increase serotonin activity and risk of serotonin syndrome
  • Phenytoin: Trazodone may increase phenytoin levels, requiring dose adjustments

Check interactions with the GMJ Interaction Checker

Dosage

For depression in adults, the typical starting dose is 150 mg daily in divided doses, which may be gradually increased to 300-400 mg daily as needed. For insomnia, much lower doses of 25-100 mg at bedtime are commonly used. Extended-release formulations may be taken once daily. Elderly patients typically start with lower doses due to increased sensitivity. Dosage should always be individualized and determined by a healthcare provider based on the specific condition being treated, patient response, and tolerance. Gradual dose reduction is recommended when discontinuing to avoid withdrawal symptoms.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Trazodone." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/trazodone/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Revolution Medicines Ships Experimental Pancreatic Cancer Drug Under Early Access

Revolution Medicines begins expanded access program for daraxonrasib targeting KRAS G12C mutations.…

NHS Patient Watchdog Abolition Sparks Concerns Over Health Service Accountability

Local councils warn that government plans to abolish NHS patient watchdogs will…

DNA Test Could Spare 6,600 Breast Cancer Patients From Unnecessary Chemotherapy

New genetic testing could spare 6,600 UK breast cancer patients annually from…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Moclobemide

By
Prof. Giorgi Pkhakadze
02/06/2026

Magnesium supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Zinc supplements

By
Prof. Giorgi Pkhakadze
02/06/2026

Phenobarbital

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up